Based on a Rock Solid Foundation
Before 2001, NiKem Research constituted the core nucleus of operations for SmithKline Beecham Discovery, Milan. In addition to the latest technologies and equipment needed for modern medicinal chemistry, our staff and management had all the extensive training and experience that can be gained by growing in a global pharmaceutical environment. Our team work was and is a key ingredient in our success.
Our Mission is to help our clients and partners rapidly translate their discovery biology output into high quality preclinical candidates.
Our Company: Experience, Teamwork and Success
The last 8 years have been a period of controlled growth
Following the formation of NiKem we have been busy investing in expanding our facilities and continually adding new value-added services to support our clients with their research. Our record of success is impressive with numerous successful preclinical candidate selections and a portfolio of very satisfied clients.
Today, NiKem has tripled its staff, has increased its research space and technology platforms with the addition of an automation laboratory, more wetlabs, GLP Bioanalysis and MS imaging. NiKem offers a complete drug discovery service to take your target all the way into pre-clinical development.
NiKem Research does not run its own internal drug discovery projects.